Evaluate the Safety of Linaclotide in IBS-C Patients in China
NCT04462900
·
clinicaltrials.gov ↗
COMPLETED
Status
3028
Enrollment
INDUSTRY
Sponsor class
Conditions
Irritable Bowel Syndrome-IBS
Sponsor
AstraZeneca